Literature DB >> 15966270

Neuropsychological tests and functional nuclear neuroimaging provide evidence of subclinical impairment in Nasu-Hakola disease heterozygotes.

Lorenza Montalbetti1, Maria Teresa Ratti, Bianca Greco, Carlo Aprile, Arrigo Moglia, Debora Soragna.   

Abstract

Nasu-Hakola disease is a rare, recessively inherited disease characterized by presenile dementia and bone cysts. Until now, no evidence of subclincal pathological changes in individuals heterozygous for the mutations underlying Nasu-Hakola disease has been reported. We performed a functional neuroimaging (99mTc-ECD SPECT) and neuropsychological study of healthy members of an Italian family carrying a mutation in the TREM2 gene. Two healthy subjects heterozygous for one mutated TREM2 allele showed a deficit of visuospatial memory associated with hypoperfusion in the basal ganglia, whereas the homozygotes for the wild-type allele of TREM2 did not show any abnormalities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15966270

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  19 in total

1.  Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.

Authors:  Laura Piccio; Yuetiva Deming; Jorge L Del-Águila; Laura Ghezzi; David M Holtzman; Anne M Fagan; Chiara Fenoglio; Daniela Galimberti; Barbara Borroni; Carlos Cruchaga
Journal:  Acta Neuropathol       Date:  2016-01-11       Impact factor: 17.088

Review 2.  Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease?

Authors:  Yuetiva Deming; Zeran Li; Bruno A Benitez; Carlos Cruchaga
Journal:  Expert Opin Ther Targets       Date:  2018-06-20       Impact factor: 6.902

3.  Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease.

Authors:  Atsushi Sasaki; Akiyoshi Kakita; Kunihiro Yoshida; Takuya Konno; Takeshi Ikeuchi; Shintaro Hayashi; Hidenori Matsuo; Kei Shioda
Journal:  Neurogenetics       Date:  2015-05-23       Impact factor: 2.660

4.  Frontobasal gray matter loss is associated with the TREM2 p.R47H variant.

Authors:  Elkin O Luis; Sara Ortega-Cubero; Isabel Lamet; Cristina Razquin; Carlos Cruchaga; Bruno A Benitez; Elena Lorenzo; Jaione Irigoyen; Maria A Pastor; Pau Pastor
Journal:  Neurobiol Aging       Date:  2014-06-17       Impact factor: 4.673

Review 5.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

6.  Integration of Neuroimaging and Microarray Datasets through Mapping and Model-Theoretic Semantic Decomposition of Unstructured Phenotypes.

Authors:  Spiro P Pantazatos; Jianrong Li; Paul Pavlidis; Yves A Lussier
Journal:  Cancer Inform       Date:  2009-06-08

7.  Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease.

Authors:  Benoit Melchior; Angie E Garcia; Bor-Kai Hsiung; Katherine M Lo; Jonathan M Doose; J Cameron Thrash; Anna K Stalder; Matthias Staufenbiel; Harald Neumann; Monica J Carson
Journal:  ASN Neuro       Date:  2010-07-12       Impact factor: 4.146

8.  Variant of TREM2 associated with the risk of Alzheimer's disease.

Authors:  Thorlakur Jonsson; Hreinn Stefansson; Stacy Steinberg; Ingileif Jonsdottir; Palmi V Jonsson; Jon Snaedal; Sigurbjorn Bjornsson; Johanna Huttenlocher; Allan I Levey; James J Lah; Dan Rujescu; Harald Hampel; Ina Giegling; Ole A Andreassen; Knut Engedal; Ingun Ulstein; Srdjan Djurovic; Carla Ibrahim-Verbaas; Albert Hofman; M Arfan Ikram; Cornelia M van Duijn; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

9.  Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement.

Authors:  Rita João Guerreiro; Ebba Lohmann; José Miguel Brás; Jesse Raphael Gibbs; Jonathan D Rohrer; Nicole Gurunlian; Burcu Dursun; Basar Bilgic; Hasmet Hanagasi; Hakan Gurvit; Murat Emre; Andrew Singleton; John Hardy
Journal:  JAMA Neurol       Date:  2013-01       Impact factor: 18.302

Review 10.  TREM2 in Alzheimer's disease.

Authors:  Teng Jiang; Jin-Tai Yu; Xi-Chen Zhu; Lan Tan
Journal:  Mol Neurobiol       Date:  2013-02-14       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.